{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:47:26Z","timestamp":1790970446973,"version":"4.1.0"},"reference-count":100,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP22K10091"],"award-info":[{"award-number":["JP22K10091"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"award":["JP22K10091"],"award-info":[{"award-number":["JP22K10091"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum neurotoxin (BoNT) injection into the masseter muscle is used in selected conditions associated with excessive or painful masseter activity, including oromandibular dystonia, masseter-related myalgia, and bruxism-associated masticatory muscle pain. However, clinical outcomes and adverse-event profiles vary widely, partly because injection technique, dose, dilution, injection depth, anatomical targeting, patient selection, and injector experience have not been consistently standardized. This review examines the anatomical and pharmacological rationale for motor endplate zone (MEZ)-targeted BoNT injection into the masseter muscle. MEZ-targeted injection is not presented as an established clinical guideline or as a proven superior technique but as a hypothesis-generating framework for future controlled studies. Anatomical and electrophysiological studies indicate that neuromuscular junctions in the masseter muscle are concentrated within relatively restricted MEZs. From a pharmacological perspective, delivery of BoNT close to these zones may allow more efficient neuromuscular blockade with lower doses, although direct clinical evidence demonstrating superiority over conventional techniques remains insufficient. Reported adverse events may be influenced by excessive dosing, inaccurate injection depth, diffusion into adjacent structures, or repeated high-dose injections. Future studies should evaluate anatomically informed, dose-minimized injection strategies using clearly defined clinical populations, standardized diagnostic criteria, detailed reporting of injection technique, objective functional outcomes, and systematic adverse-event assessment.<\/jats:p>","DOI":"10.3390\/toxins18070304","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:04:31Z","timestamp":1784016271000},"page":"304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anatomical Rationale for Motor Endplate Zone-Targeted Botulinum Toxin Injection in the Masseter Muscle: A Hypothesis-Generating Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-4347","authenticated-orcid":false,"given":"Kazuya","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, National Hospital Organization, Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5664\/jcsm.3532","article-title":"Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: A polysomnographic evaluation","volume":"10","author":"Shim","year":"2014","journal-title":"J. Clin. Sleep Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yoshida, K. (2022). Botulinum toxin therapy for oromandibular dystonia and other movement disorders in the stomatognathic system. Toxins, 14.","DOI":"10.3390\/toxins14040282"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Canales, G.D.l.T., Alvarez-Pinzon, N., Mu\u00f1oz-Lora, V.R.M., Peroni, L.V., Gomes, A.F., S\u00e1nchez-Ayala, A., Haiter-Neto, F., Manfredini, D., and Rizzatti-Barbosa, C.M. (2020). Efficacy and safety of botulinum toxin type A on persistent myofascial pain: A randomized clinical trial. Toxins, 12.","DOI":"10.3390\/toxins12060395"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: Revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007816","article-title":"Pharmacology and immunology of botulinum toxin serotypes","volume":"248","author":"Aoki","year":"2001","journal-title":"J. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","article-title":"Botulinum toxin A, brain and pain","volume":"119\u2013120","author":"Matak","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08869634.2024.2405298","article-title":"Temporomandibular disorders: INfORM\/IADR key points for good clinical practice based on standard of care","volume":"43","author":"Manfredini","year":"2025","journal-title":"Cranio"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/joor.12663","article-title":"International consensus on the assessment of bruxism: Report of a work in progress","volume":"45","author":"Lobbezoo","year":"2018","journal-title":"J. Oral Rehabil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/joor.13985","article-title":"Updating the bruxism definitions: Report of an international consensus meeting","volume":"52","author":"Verhoeff","year":"2025","journal-title":"J. Oral Rehabil."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/joor.12426","article-title":"Why not stop looking at bruxism as a black\/white condition? Aetiology could be unrelated to clinical consequences","volume":"43","author":"Manfredini","year":"2016","journal-title":"J. Oral Rehabil."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yoshida, K. (2021). Effects of botulinum toxin type A on pain among trigeminal neuralgia, myofascial temporomandibular disorders, and oromandibular dystonia. Toxins, 13.","DOI":"10.3390\/toxins13090605"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yoshida, K., and Kaji, R. (2024). Treatment with onabotulinumtoxinA for oromandibular dystonia: A systematic review and meta-analysis. Toxins, 16.","DOI":"10.3390\/toxins16120546"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.pain.2011.03.036","article-title":"Efficacy of botulinum toxin type A for treatment of persistent myofascial temporomandibular disorder pain: A randomized, controlled, double-blind multicenter study","volume":"152","author":"Ernberg","year":"2011","journal-title":"Pain"},{"key":"ref_18","first-page":"39","article-title":"Type A botulinum toxin in the treatment of chronic facial pain associated with temporomandibular dysfunction","volume":"101","year":"2001","journal-title":"Acta Neurol. Belg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0304-3959(02)00240-3","article-title":"Randomized controlled trial of botulinum toxin for chronic myogenous orofacial pain","volume":"99","author":"Nixdorf","year":"2002","journal-title":"Pain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1179\/crn.2008.017","article-title":"Efficacy of botulinum toxin in treating myofascial pain in bruxers: A controlled placebo pilot study","volume":"26","author":"Manfredini","year":"2008","journal-title":"Cranio"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.joms.2008.03.008","article-title":"Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement","volume":"66","author":"Kurtoglu","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jphotobiol.2016.03.038","article-title":"The effect of laser and botulinum toxin in the treatment of myofascial pain and mouth opening: A randomized clinical trial","volume":"159","author":"Magro","year":"2016","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0003489417693013","article-title":"IncobotulinumtoxinA injection for temporomandibular joint disorder","volume":"126","author":"Patel","year":"2017","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_24","first-page":"e112","article-title":"Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study","volume":"9","year":"2017","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/ijdr.IJDR_125_17","article-title":"Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism","volume":"28","author":"Jadhao","year":"2017","journal-title":"Indian J. Dent. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1212\/WNL.0000000000004951","article-title":"Onabotulinum toxin-A injections for sleep bruxism","volume":"90","author":"Ondo","year":"2018","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Shim, Y.J., Lee, H.J., Park, K.J., Kim, H.T., Hong, I.L., and Kim, S.T. (2020). Botulinum toxin therapy for managing sleep bruxism: A randomized and placebo-controlled trial. Toxins, 12.","DOI":"10.3390\/toxins12030168"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Montes-Carmona, J.F., Gonzalez-Perez, L.M., and Infante-Cossio, P. (2021). Treatment of localized and referred masticatory myofascial pain with botulinum toxin injection. Toxins, 13.","DOI":"10.3390\/toxins13010006"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/njcp.njcp_251_20","article-title":"Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective randomized clinical study","volume":"24","author":"Kaya","year":"2021","journal-title":"Niger. J. Clin. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.sdentj.2021.07.001","article-title":"Botulinum toxin and occlusal splints for the management of sleep bruxism in implant overdenture patients: A randomized controlled trial","volume":"33","author":"Ali","year":"2021","journal-title":"Saudi Dent. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e000328","DOI":"10.1136\/bmjno-2022-000328","article-title":"Efficacy of botulinum toxin type A in sleep bruxism: A randomized, placebo-controlled, cross-over study","volume":"4","author":"Cruse","year":"2022","journal-title":"BMJ Neurol. Open"},{"key":"ref_32","first-page":"e32180","article-title":"Low-dose botulinum toxin injection for nocturnal bruxism: A randomized controlled clinical trial","volume":"14","author":"Shehri","year":"2022","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10787-010-0069-x","article-title":"The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: A systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2011","journal-title":"Inflammopharmacology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.adaj.2016.08.022","article-title":"Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome: A systematic review and meta-analysis","volume":"147","author":"Khalifeh","year":"2016","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00784-017-2092-4","article-title":"Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review","volume":"21","author":"Manfredini","year":"2017","journal-title":"Clin. Oral Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijom.2018.05.003","article-title":"Injection therapies for temporomandibular myofascial pain: A systematic review","volume":"47","author":"Machado","year":"2018","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_37","first-page":"3411","article-title":"Adverse effects of botulinum toxin in orofacial pain","volume":"23","author":"Canales","year":"2019","journal-title":"Clin. Oral Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jop.12822","article-title":"Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction","volume":"48","author":"Awan","year":"2019","journal-title":"J. Oral Pathol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2019.08.011","article-title":"Botulinum toxin type A for painful temporomandibular disorders: Systematic review and meta-analysis","volume":"21","author":"Machado","year":"2020","journal-title":"J. Pain"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/08869634.2021.1949536","article-title":"Does botulinum toxin have any role in the management of chronic pain associated with bruxism?","volume":"42","author":"Alwayli","year":"2024","journal-title":"Cranio"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/joor.12914","article-title":"The effect of botulinum toxin injections on bruxism: A systematic review","volume":"47","author":"Sahin","year":"2020","journal-title":"J. Oral Rehabil."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.prosdent.2020.06.002","article-title":"Clinical outcomes of botulinum toxin type A injections in the management of primary bruxism in adults: A systematic review","volume":"126","author":"Sendra","year":"2021","journal-title":"J. Prosthet. Dent."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.17219\/dmp\/145759","article-title":"Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review","volume":"59","year":"2022","journal-title":"Dent. Med. Probl."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Di Francesco, F., Lanza, A., Di Blasio, M., Vaienti, B., Cafferata, E.A., Cervino, G., Cicci\u00f9, M., and Minervini, G. (2022). Application of botulinum toxin in temporomandibular disorders: A systematic review of randomized controlled trials (RCTs). Appl. Sci., 12.","DOI":"10.3390\/app122312409"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Buzatu, R., Luca, M.M., Castiglione, L., and Sinescu, C. (2024). Efficacy and safety of botulinum toxin in the management of temporomandibular symptoms associated with sleep bruxism: A systematic review. Dent. J., 12.","DOI":"10.3390\/dj12060156"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40265-024-02048-x","article-title":"Botulinum toxin-A for the treatment of myogenous temporomandibular disorders: An umbrella review of systematic reviews","volume":"84","author":"Ernberg","year":"2024","journal-title":"Drugs"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Saini, R.S., Almoyad, M.A.A., Binduhayyim, R.I.H., Quadri, S.A., Gurumurthy, V., Bavabeedu, S.S., Kuruniyan, M.S., Naseef, P.P., Mosaddad, S.A., and Heboyan, A. (2024). The effectiveness of botulinum toxin for temporomandibular disorders: A systematic review and meta-analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0300157"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.17219\/dmp\/186553","article-title":"Efficacy of botulinum toxin type A in bruxism management: A systematic review","volume":"62","author":"Yacoub","year":"2025","journal-title":"Dent. Med. Probl."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Coelho, M.S., Oliveira, J.M.D., Polmann, H., Pauletto, P., Stefani, C.M., Maciel, L.C.D.L., and Canto, G.D.L. (2025). Botulinum toxin for bruxism: An overview. Toxins, 17.","DOI":"10.3390\/toxins17050249"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/joor.13326","article-title":"Impact of botulinum toxin injection into masticatory muscles on mandibular bone: A systematic review","volume":"49","author":"Owen","year":"2022","journal-title":"J. Oral Rehabil."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/joor.13590","article-title":"Adverse effects of botulinum toxin-A injections on mandibular bone: A systematic review and meta-analysis","volume":"51","author":"Moussa","year":"2024","journal-title":"J. Oral Rehabil."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.11607\/ofph.3023","article-title":"Botulinum toxin for treating temporomandibular disorders: What is the evidence?","volume":"36","author":"Delcanho","year":"2022","journal-title":"J. Oral Facial Pain Headache"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.17219\/dmp\/200127","article-title":"Is botulinum toxin the future of orofacial pain management?","volume":"62","author":"Val","year":"2025","journal-title":"Dent. Med. Probl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: A double-blind controlled study","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00415-015-7703-x","article-title":"Practical guidance for cervical dystonia management involving treatment with botulinum toxin: A consensus statement","volume":"262","author":"Albanese","year":"2015","journal-title":"J. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","article-title":"Diffusion, spread, and migration of botulinum toxin","volume":"28","author":"Jankovic","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_57","unstructured":"Co\u00ebrs, C., and Woolf, A.L. (1959). The Innervation of Muscle: A Biopsy Study, Blackwell Scientific Publications."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1152\/physrev.1980.60.1.90","article-title":"Motor unit of mammalian muscle","volume":"60","author":"Buchthal","year":"1980","journal-title":"Physiol. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/00220345920710010801","article-title":"Electromyographic heterogeneity in the human masseter muscle","volume":"71","author":"Blanksma","year":"1992","journal-title":"J. Dent. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0003-9969(92)90119-S","article-title":"Task-related behavior of motor units in different regions of the human masseter muscle","volume":"37","author":"McMillan","year":"1992","journal-title":"Arch. Oral Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2186\/jjps.33.696","article-title":"Muscle surface fiber conduction velocity and frequency parameters EMG during fatigue of the human masseter muscle. 1. Muscle fiber conduction velocity","volume":"33","author":"Tokunaga","year":"1989","journal-title":"Ann. Jpn. Prosthodont. Soc."},{"key":"ref_62","first-page":"135","article-title":"Noninvasive estimation of the location of the end plate in the human masseter muscle using surface electromyograms with an electrode array","volume":"24","author":"Iwasaki","year":"1990","journal-title":"J. Osaka Dent. Univ."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2186\/jjps.34.825","article-title":"The distribution of myoneural junctions in the masseter muscle detected by the electrode arrays","volume":"34","author":"Iwasaki","year":"1990","journal-title":"Ann. Jpn. Prosthodont. Soc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2842.1998.00199.x","article-title":"Two-dimensional configuration of the myoneural junctions of human masticatory muscle detected with matrix electrode","volume":"25","author":"Tokunaga","year":"1998","journal-title":"J. Oral Rehabil."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/joor.13993","article-title":"Patient experiences with temporomandibular disorders: A survey on the pathways in diagnosis and treatment","volume":"52","author":"Manfredini","year":"2025","journal-title":"J. Oral Rehabil."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/joor.13411","article-title":"Standardised tool for the assessment of bruxism","volume":"51","author":"Manfredini","year":"2024","journal-title":"J. Oral Rehabil."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/08869634.2024.2333178","article-title":"The painful mind","volume":"42","author":"Kandasamy","year":"2024","journal-title":"Cranio"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Malcangi, G., Patano, A., Pezzolla, C., Riccaldo, L., Mancini, A., Di Pede, C., Inchingolo, A.D., Inchingolo, F., Bordea, I.R., and Dipalma, G. (2023). Bruxism and botulinum injection: Challenges and insights. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144586"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Serrera-Figallo, M.-A., Ruiz-De-Le\u00f3n-Hern\u00e1ndez, G., Torres-Lagares, D., Castro-Araya, A., Torres-Ferrerosa, O., Hern\u00e1ndez-Pacheco, E., and Gutierrez-Perez, J.-L. (2020). Use of botulinum toxin in orofacial clinical practice. Toxins, 12.","DOI":"10.3390\/toxins12020112"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"853","DOI":"10.5114\/ada.2019.82795","article-title":"The whole truth about botulinum toxin\u2014A review","volume":"37","author":"Witmanowski","year":"2020","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CCIDE.S396057","article-title":"Botulinum toxin injection for masseteric hypertrophy using a 6-point injection technique: A case report","volume":"15","author":"Rathod","year":"2023","journal-title":"Clin. Cosmet. Investig. Dent."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.2147\/JPR.S331036","article-title":"Trigeminal neuralgia: Current approaches and emerging interventions","volume":"14","author":"Xu","year":"2021","journal-title":"J. Pain Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ferrillo, M., Sommadossi, E., Raciti, L., Calafiore, D., Mezian, K., Tarantino, V., Vecchio, M., Longo, U.G., Losco, L., and de Sire, A. (2025). Botulinum toxin for masseter muscle hypertrophy: A review. Toxins, 17.","DOI":"10.3390\/toxins17020091"},{"key":"ref_74","first-page":"71","article-title":"Botulinum toxin in facial plastic surgery","volume":"7","author":"Favre","year":"2020","journal-title":"Plast. Aesthet. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/joor.12180","article-title":"Osteopenic consequences of botulinum toxin injections in masticatory muscles","volume":"41","author":"Raphael","year":"2014","journal-title":"J. Oral Rehabil."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4041\/kjod.2017.47.4.222","article-title":"Repeated botulinum toxin injections induce mandibular bone changes","volume":"47","author":"Lee","year":"2017","journal-title":"Korean J. Orthod."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Balanta-Melo, J., Toro-Ibacache, V., Kupczik, K., and Buvinic, S. (2019). Mandibular bone loss after botulinum toxin intervention. Toxins, 11.","DOI":"10.3390\/toxins11020084"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1038\/s41598-020-60554-w","article-title":"Decreased mandibular cortical bone quality after botulinum toxin injections","volume":"10","author":"Hong","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jocd.14160","article-title":"Complications of botulinum toxin A: An updated review","volume":"20","author":"Kroumpouzos","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Lee, H.J., Kang, I.W., Seo, K.K., Choi, Y.J., Kim, S.T., Hu, K.S., and Kim, H.J. (2017). Anatomical basis of paradoxical masseteric bulging after botulinum toxin injection. Toxins, 9.","DOI":"10.3390\/toxins9010014"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"ojae120","DOI":"10.1093\/asjof\/ojae120","article-title":"Rethinking paradoxical bulging of the masseter muscle after botulinum toxin injection","volume":"7","author":"Lin","year":"2024","journal-title":"Aesthet. Surg. J. Open Forum"},{"key":"ref_82","unstructured":"Arnold, F. (1845). Handbuch der Anatomie des Menschen, Herder."},{"key":"ref_83","unstructured":"Williams, P.L. (1995). Gray\u2019s Anatomy, Churchill Livingstone. [38th ed.]."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00276-000-0181-5","article-title":"Functional organization of the human masseter muscle","volume":"22","author":"Gaudy","year":"2000","journal-title":"Surg. Radiol. Anat."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00276-003-0125-y","article-title":"General organization of the human intramasseteric aponeuroses: Changes with ageing","volume":"25","author":"Brunel","year":"2003","journal-title":"Surg. Radiol. Anat."},{"key":"ref_86","unstructured":"Kamijo, Y. (2007). Oral Anatomy, Anatom. [3rd ed.]."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tripleo.2009.12.036","article-title":"Topography of the masseter muscle in relation to botulinum toxin type A","volume":"110","author":"Hu","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Lee, H.J., Jung, S.J., Kim, S.T., and Kim, H.J. (2021). Ultrasonographic considerations for safe and efficient botulinum neurotoxin injection in masseteric hypertrophy. Toxins, 13.","DOI":"10.3390\/toxins13010028"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Popescu, M.N., Beiu, C., Iliescu, C.A., Racovi\u021b\u0103, A., Berteanu, M., Iliescu, M.G., St\u0103nescu, A.M.A., Radaschin, D.S., and Popa, L.G. (2024). Ultrasound-guided botulinum toxin-A injections into the masseter muscle. Toxins, 16.","DOI":"10.3390\/toxins16100413"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Furuhata, A., Yoshida, K., and Isono, S. (2025). Factors influencing the effectiveness of botulinum toxin therapy in bruxism management. Toxins, 17.","DOI":"10.3390\/toxins17080384"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-282X2005000100035","article-title":"Botulinum toxin: Mechanisms of action","volume":"63","author":"Dressler","year":"2005","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: Genetic, structural, and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.27072","article-title":"Botulinum toxin: State of the art","volume":"32","author":"Jankovic","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: Differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Scaglione, F. (2016). Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice. Toxins, 8.","DOI":"10.3390\/toxins8030065"},{"key":"ref_96","first-page":"394","article-title":"Is botulinum toxin therapy effective for bruxism?","volume":"13","author":"Yoshida","year":"2017","journal-title":"Anti-Aging Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","article-title":"Response and immunoresistance to botulinum toxin injections","volume":"45","author":"Jankovic","year":"1995","journal-title":"Neurology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00702-012-0893-9","article-title":"Immunogenicity of botulinum toxins","volume":"120","author":"Naumann","year":"2013","journal-title":"J. Neural Transm."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Yoshida, K. (2020). Development and validation of a disease-specific oromandibular dystonia rating scale (OMDRS). Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.583177"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Yoshida, K. (2022). Effects of botulinum toxin therapy on health-related quality of life evaluated by the Oromandibular Dystonia Rating Scale. Toxins, 14.","DOI":"10.3390\/toxins14100656"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:10:22Z","timestamp":1784016622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":100,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["toxins18070304"],"URL":"https:\/\/doi.org\/10.3390\/toxins18070304","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}